$1.04
-0.075-6.7%
Last update: Nov 3, 12:39 PM
ProKidney Corp (PROK) Stock Price, Quote, News & History
PROKNASDAQ
Stocks up, Dow Jones +100 points. AEVEX Corp shares rose 11.8% on $50m Air Force contract. Other big gainers: ABVX +34.2%, ESBA +20.9%, AVAV +20.4%, AIRJ...
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Other companies in ProKidney’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
ProKidney has a consensus price target of $6.43.
The stock price for ProKidney (NASDAQ: PROK) is $1.045 last updated November 3, 2026 at 12:39 PM EST.
There are no upcoming dividends for ProKidney.
ProKidney does not have any upcoming earnings scheduled.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its...
